drugset / Trial / NCT06958146

Azithromycin for Preventing Maternal and Neonatal Infections During Labor.

NCT06958146

Phase 4 Not yet recruiting 400 enrolled Armed Forces Hospital, Pakistan
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother

Timeline

Start
2025-05-01
Primary completion
2025-08-31
Completion
2025-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 2 g Oral

Indications